The karolinska Institute
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vollenhoven, Ronald F van
NORD-STAR, NCT01491815 / 2011-004720-35: Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction

Active, not recruiting
4
812
Europe, RoW
Non-biological DMARD's, Cimzia, Orencia, RoActemra
Karolinska Institutet
Rheumatoid Arthritis
07/23
12/23
NCT02466581 / 2014-002374-36: Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity

Active, not recruiting
4
25
Europe
Sulphasalazine + Hydroxychloroquine OR Prednisolone, SSZ+HCQ or Prednisolone, Cimzia, Certolizumab-pegol, Orencia, Abatacept, RoActemra, Tocilizumab
Karolinska Institutet
Rheumatoid Arthritis
07/23
12/23
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Recruiting
3
540
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/25
03/26
Rezaei, Hamed
No trials found

Download Options